UNH:NYSEUnitedHealth Group Incorporated Analysis
Data as of 2026-08-08 - not real-time
$407.08
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
UnitedHealth Group Incorporated trades at $407.08, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. It has lost 2.0% over the past 30 days. RSI sits at 44.0, which reads as neutral, and MACD momentum is bearish. Watch $397.80 as support and $461.62 as the nearer resistance level.
Valuation screens as fair: a P/E of 30.4 sits in line with the sector average of 29.5. Consensus targets land 16.7% above where the shares trade now. The 2.30% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 26.8%, a beta of 0.44 and a maximum drawdown of 30.0%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 4/10 conviction over the longer horizon.
Valuation screens as fair: a P/E of 30.4 sits in line with the sector average of 29.5. Consensus targets land 16.7% above where the shares trade now. The 2.30% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 26.8%, a beta of 0.44 and a maximum drawdown of 30.0%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 4/10 conviction over the longer horizon.
Top Market Events
The healthcare giant is working to stabilize margins by shrinking membership, exiting unprofitable contracts and...Seeking Alpha22dUnitedHealth rallies on upbeat forecast; these ETFs have the highest exposureUnitedHealth Group UNH...Health insurance company UnitedHealth NYSE:UNH announced in Q2 CY2026, but sales were flat year on year at $112 billion.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 5/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 345.93
- MACD momentum is negative
Medium Term
1–3 yearsPositive
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 30.4 versus sector average of 29.5
- Trading above the 200-day average of 345.93
Long Term
> 3 yearsNeutral
Model confidence: 4/10
Key Factors
- P/E of 30.4 versus sector average of 29.5
- Analyst targets imply +16.7% versus the current price
- Dividend yield of 2.30%
Key Metrics & Analysis
Financial Health
Revenue Growth0.40%
Profit Margin3.14%
P/E Ratio30.4
ROE14.15%
ROA4.38%
Debt/Equity69.21
P/B Ratio3.5
Op. Cash Flow$27.0B
Free Cash Flow$22.8B
Industry P/E29.5
Technical Analysis
TrendBullish
RSI44.0
Support$397.80
Resistance$461.62
MA 20$420.27
MA 50$412.80
MA 200$345.93
MACDBearish
VolumeDecreasing
Fear & Greed Index94.82
Valuation
Fair Value$280.28
Target Price$475.23
Upside/Downside16.74%
GradeFair
TypeBlend
Dividend Yield2.30%
Risk Assessment
Beta0.44
Volatility26.82%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.